Abingdon Health Plc

Equities

ABDX

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Delayed London S.E. Other stock markets 03:39:15 2024-04-30 am EDT			5-day change	1st Jan Change
9.856 ^GBX	-1.44%		-6.13%	-10.40%

Mar. 25	Peel Hunt's RetailBook raises GBP2.5 million	AN
Mar. 25	Abingdon Health Completes Design Freeze for STD Self-Tests	MT

Abingdon Health Plc Announces Promotion of Laura Towse as Group Financial Controller

January 11, 2024 at 02:00 am EST

The Board of Abingdon Health Plc confirmed the promotion of Laura Towse, who has been with the business since June 2023, to Group Financial Controller effective 1 January 2024. Laura will report into Chris Yates, CEO, who is a qualified Chartered Accountant.

Latest news about Abingdon Health Plc

Peel Hunt's RetailBook raises GBP2.5 million	Mar. 25	AN
Abingdon Health Completes Design Freeze for STD Self-Tests	Mar. 25	MT
Abingdon Health to Provide Rapid Self-tests to Boots	Mar. 20	MT
Abingdon Health strikes deal amidst upswing in self testing market	Mar. 20	AN
AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement	Mar. 20	AN
EARNINGS AND TRADING: Smarttech247 and Beeks in deal boosts	Mar. 14	AN
AIM WINNERS & LOSERS: Smartspace backs Sign In bid; Abingdon jumps	Mar. 14	AN
London stocks tread water with US data to come	Mar. 14	AN
ABINGDON HEALTH PLC: BOARD EXPECTS THAT H2 REVENUE WILL BE SIGN…	Mar. 14	RE
Abingdon Health plc Provides Earnings Guidance for the Second Half and Full Fiscal Year 2024	Mar. 14	CI
Abingdon Health Plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 14	CI
Abingdon Health shares down despite decent interim results	Jan. 11	AN
Abingdon Health Plc Announces Promotion of Laura Towse as Group Financial Controller	Jan. 11	CI
Abingdon Health plc Announces Resignation of Andrew Feather as Interim Finance Director	Jan. 11	CI
Abingdon Health Plc Reports Revenue Results for the Six Months Ended December 31, 2023	Jan. 11	CI
Abingdon expects higher half-year revenue	Dec. 15	AN
Stocks edge higher ahead of slew of PMIs	Dec. 15	AN
FTSE 100 Closes Up on Tech Earnings Expectations, Easing Bond Yields	23-10-24	DJ
Abingdon Health appoints Feather as new interim finance director	23-10-24	AN
Abingdon Health Names Interim Finance Director	23-10-24	MT
Abingdon Health Plc Announces Executive Changes	23-10-24	CI
FTSE 100 Closes Down 1.1% on Middle East Tensions	23-10-18	DJ
Abingdon Health finance chief resigns, seeks interim hire	23-10-18	AN
Abingdon Health CFO Plans Exit; Stock Drops	23-10-18	MT
Abingdon Health plc Announces Resignation of Melanie Ross as Director	23-10-18	CI

Chart Abingdon Health Plc

Duration

Period

More charts

Company Profile

Abingdon Health plc is a lateral flow contract development and manufacturing organization (CDMO). The Company develops, manufactures, and distributes diagnostic devices and provides consultancy services to businesses in the diagnostics sector. Its segments include Product sales, Contract manufacturing, and Contract development. Its customer base across industry sectors includes clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-11-13 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
ABINGDON HEALTH PLC	-10.40%	38.65M
BIOMÉRIEUX	+1.09%	12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-7.57%	7.84B
DIASORIN S.P.A.	+2.92%	5.5B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.93%	4.61B
LANTHEUS HOLDINGS, INC.	+8.48%	4.61B
ANDON HEALTH CO., LTD.	+9.21%	2.66B
VITROLIFE AB	-14.07%	2.08B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.63%	1.72B
MYRIAD GENETICS, INC.	+3.45%	1.79B

Diagnostic & Testing Substances